In our study, most diabetic patients with hypertension have taken an angiotensin converting enzyme inhibitor or angiotensin receptor blocker medication, which slows the progression of diabetic nephropathy and reduces albuminuria.25,26 This could interfere with genetic effects on the development of albuminuria in these patients. This evidence concerns the gene ACE and diabetic kidney disease.